Compare Signpost Corp. (Tokyo) with Similar Stocks
Dashboard
1
Poor Management Efficiency with a low ROE of 5.07%
- The company has been able to generate a Return on Equity (avg) of 5.07% signifying low profitability per unit of shareholders funds
2
Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -64.17
3
Poor long term growth as Net Sales has grown by an annual rate of 9.03% and Operating profit at 16.70% over the last 5 years
4
Positive results in May 26
5
With ROE of 4.07%, it has a very expensive valuation with a 1.19 Price to Book Value
Stock DNA
Pharmaceuticals & Biotechnology
JPY 2,575 Million (Micro Cap)
29.00
NA
0.00%
-1.10
6.10%
1.36
Revenue and Profits:
Net Sales:
908 Million
(Quarterly Results - May 2026)
Net Profit:
14 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-51.36%
0%
-51.36%
6 Months
-56.03%
0%
-56.03%
1 Year
-70.33%
0%
-70.33%
2 Years
-60.83%
0%
-60.83%
3 Years
-77.69%
0%
-77.69%
4 Years
-77.54%
0%
-77.54%
5 Years
-89.73%
0%
-89.73%
Signpost Corp. (Tokyo) for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
9.03%
EBIT Growth (5y)
16.70%
EBIT to Interest (avg)
-17.12
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.76
Sales to Capital Employed (avg)
1.37
Tax Ratio
12.35%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
17.97%
ROE (avg)
5.07%
Valuation key factors
Factor
Value
P/E Ratio
29
Industry P/E
Price to Book Value
1.19
EV to EBIT
9.41
EV to EBITDA
9.36
EV to Capital Employed
1.64
EV to Sales
0.29
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
17.42%
ROE (Latest)
4.07%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
Bullish
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - May'26 - QoQ
May'26
Nov'25
Change(%)
Net Sales
908.10
797.10
13.93%
Operating Profit (PBDIT) excl Other Income
-2.40
27.30
-108.79%
Interest
1.20
1.30
-7.69%
Exceptional Items
0.00
-0.40
100.00%
Consolidate Net Profit
14.50
25.00
-42.00%
Operating Profit Margin (Excl OI)
-2.80%
34.00%
-3.68%
USD in Million.
Net Sales
Not Applicable: The company has declared_date for only one period
Consolidated Net Profit
Not Applicable: The company has declared_date for only one period
Annual Results Snapshot (Consolidated) - Feb'26
Feb'26
Feb'25
Change(%)
Net Sales
3,138.90
3,023.50
3.82%
Operating Profit (PBDIT) excl Other Income
98.90
200.20
-50.60%
Interest
9.00
2.70
233.33%
Exceptional Items
-0.40
-1.30
69.23%
Consolidate Net Profit
76.20
257.20
-70.37%
Operating Profit Margin (Excl OI)
31.40%
66.20%
-3.48%
USD in Million.
Net Sales
YoY Growth in year ended Feb 2026 is 3.82% vs 3.20% in Feb 2025
Consolidated Net Profit
YoY Growth in year ended Feb 2026 is -70.37% vs 99.69% in Feb 2025
About Signpost Corp. (Tokyo) 
Signpost Corp. (Tokyo)
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






